Insider trade

Andrew Dudum, CEO at Hims & Hers Health, sold ~$665K of Hims & Hers Health shares.

~$665K
Approx. value · 10K sh @ $63.49
151K
Holds after · shares reported
Traded
Oct 16, 2025
Filed
Oct 20, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 4, 2025CongressDisclosed purchase of HIMS — reported range $1,001 - $15,000
  2. Aug 18, 2025Insider · 1 personInsiders: 6 sales (~$7.9M)
  3. Aug 25, 2025InsiderOfficer sold ~$114K of HIMS shares in the open market
  4. Aug 26, 2025InsiderCFO sold ~$506K of HIMS shares in the open market
  5. Sep 1, 2025Company filing · Form 8-K · Material agreementSigned an important agreement
  6. Sep 15, 2025Insider · 2 peopleInsiders: 3 sales (~$8.3M)
  7. Sep 16, 2025Insider · 1 personInsiders: 9 sales (~$9.4M)
  8. Sep 17, 2025Insider · 5 peopleInsiders: 5 sales (~$5.1M)
  9. Sep 22, 2025InsiderCFO sold ~$1.36M of HIMS shares in the open market
  10. Sep 24, 2025InsiderOfficer sold ~$119K of HIMS shares in the open market
  11. Sep 28, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 28, 2025, Nader Kabbani, the Chief Operating Officer of Hims & Hers Health, Inc. (the “Company”) determined to step into a new advisory role for the Company effective November 2, 2025 (the “Transition Date”), where he will continue to provide ongoing strategic guidance to the Company and support for special global initiatives through July 2026.”
  12. Sep 29, 2025Insider · 2 peopleInsiders: 2 sales (~$5.3M)
  13. Oct 3, 2025InsiderCFO sold ~$669K of HIMS shares in the open market
  14. Oct 10, 2025InsiderOfficer sold ~$52K of HIMS shares in the open market
  15. Oct 13, 2025InsiderOfficer sold ~$143K of HIMS shares in the open market
  16. Oct 16, 2025 · this disclosureInsiderCEO sold ~$665K of HIMS shares in the open market

What came next

  1. Oct 16, 2025Insider · 1 personInsiders: 8 sales (~$10.4M)
  2. Oct 17, 2025InsiderCFO sold ~$662K of HIMS shares in the open market
  3. Oct 27, 2025InsiderOfficer sold ~$132K of HIMS shares in the open market
  4. Nov 3, 2025Company filing · Form 8-K · ResultsReported its results
  5. Nov 10, 2025InsiderOfficer sold ~$112K of HIMS shares in the open market
  6. Nov 17, 2025InsiderCFO sold ~$853K of HIMS shares in the open market
  7. Nov 24, 2025InsiderOfficer sold ~$93K of HIMS shares in the open market
  8. Dec 9, 2025InsiderDirector sold ~$98K of HIMS shares in the open market
  9. Dec 17, 2025Insider · 4 peopleInsiders: 4 sales (~$1.4M)
  10. Dec 22, 2025InsiderCFO sold ~$825K of HIMS shares in the open market
  11. Jan 5, 2026InsiderCFO sold ~$306K of HIMS shares in the open market
  12. Jan 20, 2026InsiderCFO sold ~$275K of HIMS shares in the open market
  13. Feb 3, 2026InsiderCFO sold ~$139K of HIMS shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Hims & Hers Health

For Hims & Hers Health, OQRO holds 14 insider filings (SEC Form 4 or Form 144) and 4 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HIMS page.

Other recent filings by Andrew Dudum, Chief Executive Officer

The full history of Andrew Dudum, Chief Executive Officer is on the profile page.

How this filing works

Other disclosures at Hims & Hers Health

Everything OQRO holds on this company is on its HIMS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data